- Home
- REPL vs CVLG Comparison
REPL vs CVLG Comparison
Compare REPL & CVLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- CVLG
- Stock Information
- Founded
- REPL 2015
- CVLG 1986
- Country
- REPL United States
- CVLG United States
- Employees
- REPL N/A
- CVLG N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- CVLG Trucking Freight/Courier Services
- Sector
- REPL Health Care
- CVLG Industrials
- Exchange
- REPL Nasdaq
- CVLG Nasdaq
- Market Cap
- REPL 780.3M
- CVLG 718.4M
- IPO Year
- REPL 2018
- CVLG 1994
- Fundamental
- Price
- REPL $11.85
- CVLG $27.87
- Analyst Decision
- REPL Strong Buy
- CVLG Strong Buy
- Analyst Count
- REPL 6
- CVLG 2
- Target Price
- REPL $17.50
- CVLG $34.75
- AVG Volume (30 Days)
- REPL 818.5K
- CVLG 92.3K
- Earning Date
- REPL 02-06-2025
- CVLG 01-23-2025
- Dividend Yield
- REPL N/A
- CVLG 1.19%
- EPS Growth
- REPL N/A
- CVLG N/A
- EPS
- REPL N/A
- CVLG 1.51
- Revenue
- REPL N/A
- CVLG $1,128,130,000.00
- Revenue This Year
- REPL N/A
- CVLG $5.29
- Revenue Next Year
- REPL $300.41
- CVLG $6.37
- P/E Ratio
- REPL N/A
- CVLG $18.39
- Revenue Growth
- REPL N/A
- CVLG 0.22
- 52 Week Low
- REPL $4.92
- CVLG $21.52
- 52 Week High
- REPL $17.00
- CVLG $30.77
- Technical
- Relative Strength Index (RSI)
- REPL 51.79
- CVLG 52.33
- Support Level
- REPL $10.05
- CVLG $27.56
- Resistance Level
- REPL $11.20
- CVLG $28.21
- Average True Range (ATR)
- REPL 0.92
- CVLG 0.70
- MACD
- REPL -0.08
- CVLG 0.12
- Stochastic Oscillator
- REPL 51.97
- CVLG 80.00
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About CVLG Covenant Logistics Group Inc.
Covenant Logistics Group Inc together with its wholly-owned subsidiaries offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight and Warehousing. Expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. Managed Freight segment includes brokerage services and TMS. Warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function. Majority of revenue is generated from expedited segment.